Neurodegeneration

Alzheimer’s disease, Parkinson’s disease, ALS (amyotrophic lateral sclerosis) and other neurodegenerative diseases are all very challenging therapeutic area. In particular, RIPK1 is a hot target for new drug design.
View as Grid List

Items 1-12 of 24

Page
per page
Set Descending Direction
View as Grid List

Items 1-12 of 24

Page
per page
Set Descending Direction
Copyright © 1999-2020 Qventas Lab All rights reserved.